Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis

被引:38
作者
Cohen, AT
Wagner, MB
Mohamed, MS
机构
[1] EPIDEMIOL BIOESTATIST & INFORMAT,PORTO ALEGRE,RS,BRAZIL
[2] WILLIAM HARVEY HOSP,ASHFORD,KENT,ENGLAND
关键词
D O I
10.1016/S0002-9610(97)00050-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Patients undergoing major abdominal surgery are at risk of both bleeding and thrombotic complications and usually receive heparin thromboprophylaxis. PATIENTS AND METHODS: Risk factors for perioperative bleeding were examined in 3,809 patients in a double-blind, randomized trial investigating heparin thromboprophylaxis. The risk factors were modeled by logistic regression, and a risk score was calculated using the significant factors in the model. RESULTS: Bleeding was associated with the following factors in the model, given as adjusted odds ratios (ORa [95% confidence interval]): male sex (ORa 1.68 [1.21 to 2.34] P = 0.003), malignancy (ORa 1.69 [1.21 to 2.34] P = 0.008), gynecological surgery (ORa 1.62 [1.12 to 2.35] P = 0.011), and complex surgery (ORa 2.7 [2.02 to 3.62] P < 0.001). The risk of excessive bleeding for 0, 1, 2, and 3 risk factors was 2%, 6%, 11%, and 21%, respectively. CONCLUSIONS: The recognition of patients with these risk factors associated with perioperative bleeding should result in increased vigilance and may lead to modification of surgical and medical therapy. (C) 1997 by Excerpta Medica, Inc.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 31 条
[1]   LOW-MOLECULAR-WEIGHT HEPARIN ONCE DAILY COMPARED WITH CONVENTIONAL LOW-DOSE HEPARIN TWICE DAILY - A PROSPECTIVE DOUBLE-BLIND MULTICENTER TRIAL ON PREVENTION OF POSTOPERATIVE THROMBOSIS [J].
BERGQVIST, D ;
BURMARK, US ;
FRISELL, J ;
HALLBOOK, T ;
LINDBLAD, B ;
RISBERG, B ;
TORNGREN, S ;
WALLIN, G .
BRITISH JOURNAL OF SURGERY, 1986, 73 (03) :204-208
[2]   EXHAUSTED PLATELETS IN PATIENTS WITH MALIGNANT SOLID TUMORS WITHOUT EVIDENCE OF ACTIVE CONSUMPTION COAGULOPATHY [J].
BONEU, B ;
BUGAT, R ;
BONEU, A ;
ECHE, N ;
SIE, P ;
COMBES, PF .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (07) :899-903
[3]   COMPARISON OF LOW-MOLECULAR WEIGHT HEPARIN VS UNFRACTIONATED HEPARIN IN GYNECOLOGICAL SURGERY [J].
BORSTAD, E ;
URDAL, K ;
HANDELAND, G ;
ABILDGAARD, U .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (02) :99-103
[4]  
BRIEL RC, 1983, INT SURG, V68, P241
[5]  
CAEN JP, 1988, THROMB HAEMOSTASIS, V59, P216
[6]   REDUCTION IN FATAL PULMONARY-EMBOLISM AND VENOUS THROMBOSIS BY PERIOPERATIVE ADMINISTRATION OF SUBCUTANEOUS HEPARIN - OVERVIEW OF RESULTS OF RANDOMIZED TRIALS IN GENERAL, ORTHOPEDIC, AND UROLOGIC SURGERY [J].
COLLINS, R ;
SCRIMGEOUR, A ;
YUSUF, S ;
PETO, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1162-1173
[7]  
DEJONG E, 1987, THROMB HAEMOSTASIS, V57, P140
[8]   LOW-DOSE HEPARIN VERSUS LOW-MOLECULAR WEIGHT HEPARIN (KABI 2165, FRAGMIN) IN THE PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS OF ABDOMINAL ONCOLOGICAL SURGERY [J].
FRICKER, JP ;
VERGNES, Y ;
SCHACH, R ;
HEITZ, A ;
EBER, M ;
GRUNEBAUM, L ;
WIESEL, ML ;
KHER, A ;
BARBIER, P ;
CAZENAVE, JP .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (06) :561-567
[9]   PROPHYLAXIS OF THROMBOEMBOLISM IN GENERAL-SURGERY - COMPARISON BETWEEN STANDARD HEPARIN AND FRAGMIN [J].
HARTL, P ;
BRUCKE, P ;
DIENSTL, E ;
VINAZZER, H .
THROMBOSIS RESEARCH, 1990, 57 (04) :577-584
[10]  
HIRSH J, 1992, BLOOD, V79, P1